ReviewProbiotics and antimicrobial proteins2026
Bioactive Peptides from Bovine Colostrum: Sources, Structures, and Biomedical Applications.
Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bovine colostrum (BC) is the first milk produced in the first few days after birth, notable for its high concentration of nutrients and immune factors, and clearly distinct from mature milk. Colostrum contains numerous proteins and bioactive peptides derived from them that support the growth, development, and immunological defenses of newborns. These peptides are primarily derived from major colostral proteins such as caseins, immunoglobulins (Igs), lactoferrin (Lf), and α-lactalbumin (α-La) through the action of digestive and enzymatic processes. These peptides possess antimicrobial, antitumor, anti-inflammatory, antifungal, antihypertensive, antioxidant, antiviral, and antiparasitic properties and are worthy of significant research. Recent studies have highlighted their role in enhancing mucosal immunity, maintaining gut integrity, promoting tissue regeneration, and preventing microbial infections. However, challenges such as low bioavailability, enzymatic degradation, and regulatory limitations restrict their clinical translation. Advances in delivery systems-such as encapsulation and nanoformulations-have shown promise in improving their stability and targeted action. Based on these studies, BC-derived bioactive peptides appear to have promising potential in many diseases and clinical applications in the future. This review shows a comprehensive summary of the sources, molecular characteristics, and biomedical applications of BC-derived peptides, emphasizing their potential as multifunctional agents in health promotion and disease prevention.
Indexed as
Identifiers
42033559What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.